Results
1 -
7 of
7
(Click
here to explore results)
- Ligand-based homology modelling of the human CB2 receptor SR144528 antagonist binding site: a computational approach to explore the 1,5-diaryl pyrazole scaffold. Elena Cichero, Giulia Menozzi, Sara Guariento, Paola Fossa
, Med. Chem. Commun.
, 2015
, 6
, 1978
- Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold. Anna G. Cooper, Caitlin R. M. Oyagawa, Jamie J. Manning, Sameek Singh, Sarah Hook, Natasha L. Grimsey, Michelle Glass, Joel D. A. Tyndall, Andrea J. Vernall
, Med. Chem. Commun.
, 2018
, 9
, 2055
- Indole compounds with N-ethyl morpholine moieties as CB2 receptor agonists for anti-inflammatory management of pain: synthesis and biological evaluation. Jiaojiao Li, Jing Ji, Ruibo Xu, Zhengfu Li
, Med. Chem. Commun.
, 2019
, 10
, 1935
- Pyrazole carboxamides and carboxylic acids as protein kinase inhibitors in aberrant eukaryotic signal transduction: induction of growth arrest in MCF-7 cancer cells. Tobias Persson, Christina W. Yde, Jakob E. Rasmussen, Tine L. Rasmussen, Barbara Guerra, Olaf-Georg Issinger, John Nielsen
, Org. Biomol. Chem.
, 2007
, 5
, 3963
- Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain. Samuel D. Banister, Kaavya Krishna Kumar, Vineet Kumar, Brian K. Kobilka, Sanjay V. Malhotra
, Med. Chem. Commun.
, 2019
, 10
, 647
- Rational drug design of CB2 receptor ligands: from 2012 to 2021. Yan-ran Wu, Jia-qin Tang, Wan-nian Zhang, Chun-lin Zhuang, Ying Shi
, RSC Adv.
, 2022
, 12
, 35242
- From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. Raphael Mechoulam, Shimon Ben-Shabat
, Nat. Prod. Rep.
, 1999
, 16
, 131